The S&P 500 Is Doing Something Unseen in More Than 100 Years -- Here's What History Says Happens Next

The S&P 500 is trading at extremely elevated valuations, with the Shiller P/E above 41, market cap at roughly 2x trailing-12-month GDP, and the GDP-adjusted valuation at a 100+ year high. Offset against that is strong earnings momentum, including 28.6% first-quarter aggregate earnings growth and projected 22.8% full-year growth, while credit spreads remain near historic lows, signaling continued risk appetite. The article argues these conditions could allow the bull market to keep running, though it urges investors to remain valuation-conscious.

Analysis

The setup is less “bubble about to burst” than “late-cycle melt-up with fragile internals.” Elevated multiples can persist when nominal earnings are still accelerating and credit markets are refusing to price recession; the more important signal is that both equities and credit are currently validating the same growth regime. That usually favors large-cap quality, but it also means passive ownership is getting more expensive relative to the dispersion opportunity in single names.

The second-order effect is that strong earnings growth disproportionately benefits the market’s highest beta compilers of index-level growth while leaving capital-light laggards behind. If spreads stay tight, refinancing risk stays muted and balance sheets remain a non-issue, which is supportive for lower-quality duration-sensitive equities; but once spreads widen, the unwind can be abrupt because positioning is crowded and valuation support is thin. That creates a regime where broad index exposure may underperform a barbell of profitable secular growers and defensive free-cash-flow compounders.

The key contrarian point is that “high valuation” alone is not a catalyst. The catalyst is a turn in earnings breadth or credit, and neither is evident yet; that argues against fighting the tape too early. However, the market is increasingly dependent on continued earnings surprise, so any slowdown in 2026 growth expectations would likely compress multiples quickly because there is little valuation cushion left.

CME is a subtle beneficiary here: elevated volatility in rates/credit and sustained demand for hedging instruments should keep activity supportive even if broad equity returns flatten. By contrast, the article’s highlighted long-duration beneficiaries like NFLX and NVDA are not helped by the valuation debate itself; they benefit only if growth remains exceptional, which raises the bar for follow-through. The bigger loser on a future regime shift is the broad index proxy, not because earnings collapse immediately, but because multiple contraction can dominate even if profits keep rising modestly.

Key Decisions for Investors

• Stay long quality growth but replace broad S&P exposure with a basket of higher-conviction winners; prefer names with durable earnings surprise potential over index beta for the next 3-6 months.
• Initiate a tactical long CME / short SPY pair over the next 1-2 quarters: if rates volatility or credit hedging demand stays elevated, CME should hold up while SPY remains exposed to multiple compression.
• Use call spreads rather than outright longs on high-duration leaders like NVDA into the next earnings cycle; the market is paying for perfection, so defined-risk upside is better than paying full premium.
• If credit spreads widen 25-50 bps from current levels, reduce cyclical equity exposure quickly and add index hedges via put spreads on SPY or QQQ for a 2-4 month window.
• Do not short the S&P 500 outright solely on valuation; wait for confirmation from earnings revisions or credit deterioration, since the current regime can persist for multiple quarters.